Abstract
Indonesian herbal medicines made from mixtures of several plants are called “Jamu.” The efficacy of a particular Jamu is determined by its ingredients i.e. the composition of the plants. Thus, we modeled the ingredients of Jamu formulas using Partial Least Squares Discriminant Analysis (PLS-DA) in order to predict their efficacy. The plants used in each Jamu medicine served as the predictors, whereas the efficacy of each Jamu provided the responses. Utilizing response predictions obtained from PLS-DA, we predicted the efficacies of Jamu formulations using two methods: maximum response prediction and maximum probability. In predictions of Jamu efficacy, the maximum response prediction method produced a smaller error than that the maximum probability method. Furthermore, utilizing the PLSDA coefficient matrix, we determined the efficacy for which a plant is most useful, based on its largest coefficients.
Keywords: Efficacy, Jamu, main ingredients, medicinal plant, multivariate analysis, PLS-DA, regression coefficient, response prediction, formulation, modelling
Current Computer-Aided Drug Design
Title:Efficacy Prediction of Jamu Formulations by PLS Modeling
Volume: 9 Issue: 1
Author(s): Farit M. Afendi, Latifah K. Darusman, Aki Hirai Morita, Md. Altaf-Ul-Amin, Hiroki Takahashi, Kensuke Nakamura, Ken Tanaka and Shigehiko Kanaya
Affiliation:
Keywords: Efficacy, Jamu, main ingredients, medicinal plant, multivariate analysis, PLS-DA, regression coefficient, response prediction, formulation, modelling
Abstract: Indonesian herbal medicines made from mixtures of several plants are called “Jamu.” The efficacy of a particular Jamu is determined by its ingredients i.e. the composition of the plants. Thus, we modeled the ingredients of Jamu formulas using Partial Least Squares Discriminant Analysis (PLS-DA) in order to predict their efficacy. The plants used in each Jamu medicine served as the predictors, whereas the efficacy of each Jamu provided the responses. Utilizing response predictions obtained from PLS-DA, we predicted the efficacies of Jamu formulations using two methods: maximum response prediction and maximum probability. In predictions of Jamu efficacy, the maximum response prediction method produced a smaller error than that the maximum probability method. Furthermore, utilizing the PLSDA coefficient matrix, we determined the efficacy for which a plant is most useful, based on its largest coefficients.
Export Options
About this article
Cite this article as:
M. Afendi Farit, K. Darusman Latifah, Hirai Morita Aki, Altaf-Ul-Amin Md., Takahashi Hiroki, Nakamura Kensuke, Tanaka Ken and Kanaya Shigehiko, Efficacy Prediction of Jamu Formulations by PLS Modeling, Current Computer-Aided Drug Design 2013; 9 (1) . https://dx.doi.org/10.2174/1573409911309010005
DOI https://dx.doi.org/10.2174/1573409911309010005 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Chlorophyll Catabolite Pheophorbide a as a Photosensitizer for the Photodynamic Therapy
Current Medicinal Chemistry Natural Products as PI3K/ Akt Inhibitors: Implications in Preventing Hepatocellular Carcinoma
Current Molecular Pharmacology Progress in the Discovery of Polo-like Kinase Inhibitors
Current Topics in Medicinal Chemistry Current Applications of Artificial Neural Networks in Biochemistry with Emphasis on Cancer Research
Current Biochemical Engineering (Discontinued) Psoriasin, A Multifunctional Player in Different Diseases
Current Protein & Peptide Science Effects of Quercetin against Mycotoxin Induced Cytotoxicity: A Mini- Review
Current Nutrition & Food Science Restoration of Antitumor Immunity Through Selective Inhibition of Myeloid Derived Suppressor Cells by Anticancer Therapies
Current Molecular Medicine Advances in Clinical Study of Curcumin
Current Pharmaceutical Design Non-Melanoma Skin Cancer – Overview
Current Cancer Therapy Reviews The Prognosis of Patients with Liver Metastases from Colorectal Cancer still Depends on Anatomical Presentation more than on Treatments
Current Cancer Drug Targets The Challenges of Modeling Drug Resistance to Antiangiogenic Therapy
Current Drug Targets Influence of the Bystander Effect on HSV-tk / GCV Gene Therapy. A Review.
Current Gene Therapy Cancer Control by Phytochemicals
Current Pharmaceutical Design Elastin-Like Recombinamers As Smart Drug Delivery Systems
Current Drug Targets The Role of Pemetrexed in Lung Adenocarcinoma, Mixed Subtype with Bronchioloalveolar Carcinoma Features
Current Drug Targets Stress, Cardiovascular Diseases and Surgery-Induced Angiogenesis
Current Angiogenesis (Discontinued) Free Radicals and Antioxidants: How to Reestablish Redox Homeostasis in Chronic Diseases?
Current Medicinal Chemistry Enzyme-responsive Nanoparticles for Anticancer Drug Delivery
Current Nanoscience Anticancer Metallotherapeutics in Preclinical Development
Current Medicinal Chemistry Ontogenic Development and Population Dynamics of Hepatic Dendritic Cells
Current Immunology Reviews (Discontinued)